Deaths from cervical cancer have fallen by more than 40% over the last 20 years, mainly because of early detection and treatment. The cervical screening process has played an integral part in decreasing deaths from cervical cancer. Also with the development of new cancer vaccines women now have a greater chance of winning the fight against cervical cancer.
From September 2008, in the UK, all girls aged between 12 and 13 years will be offered routine cervical cancer vaccination. A phase catch-up programme for girls up to 18 years of age will be introduced, starting from september 2009 for England & Wales. To date no decision has been made by the Department of Health on which of the two available HPV vaccines will be used.
The IGP provide both Gardasil and Cervarix vaccinations to those who fall ouside of the governments recommended programme and to anyone who is concerned about cervical cancer & HPV.
GARDASIL & CERVARIX is a vaccine designed for the prevention of cervical, vulvar, and vaginal cancers and for males and females for the prevention of anal cancer, precancerous or dysplastic lesions, and genital warts caused by human papillomavirus (HPV) Types 6, 11, 16, and 18.
These vaccines are not recommended for use in pregnant women.
These Vaccines should be administered in 3 separate intramuscular injections. The first dose is administered at an elected date, the second dose 2 months after the first dose, and the third dose 6 months after the first dose.
For More Information Or To Arrange An Appointment Please Contact 03456 252 252